T1	Participants 58 110	patients with relapsing-remitting multiple sclerosis
T2	Participants 614 814	Inclusion criteria were one or more relapses in the year before entry and at least one gadolinium enhancing (GdE) lesion on screening MRI. Of 720 patients screened, 306 eligible patients were enrolled
T3	Participants 816 842	Patients, aged 18-50 years
T4	Participants 1882 1926	a patient with underlying hypercoagulability
